Effects of OnabotulinumtoxinA Treatment on Disability and Quality of Life in Patients with Chronic Migraine with Baseline Allodynia: A COMPEL Subanalysis

被引：0
作者：
Young, William B. [1 ]
Rothrock, John F. [2 ]
Lopez, J. Ivan [3 ]
Adams, Aubrey Manack [4 ]
Blumenfeld, Andrew M. [5 ]
机构：
[1] Jefferson Hosp Neurosci, Philadelphia, PA USA
[2] George Washington Sch Med, Washington, DC USA
[3] Univ South Alabama, Coll Med, Mobile, AL 36688 USA
[4] Allergan Plc, Irvine, CA USA
[5] Headache Ctr Southern Calif, Neurol Ctr, Carlsbad, CA USA
来源：
NEUROLOGY | 2018年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P4.133
引用
收藏
页数：2
相关论文
共 50 条
  • [31] OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine
    Lipton, R. B.
    Varon, S. F.
    Grosberg, B.
    McAllister, P. J.
    Freitag, F.
    Aurora, S. K.
    Dodick, D. W.
    Silberstein, S. D.
    Diener, H. C.
    DeGryse, R. E.
    Nolan, M. E.
    Turkel, C. C.
    NEUROLOGY, 2011, 77 (15) : 1465 - 1472
  • [32] OnabotulinumtoxinA Treatment in Chronic Migraine: Investigation of Its Effects on Disability, Headache and Neck Pain Intensity
    Onan, Dilara
    Bentivegna, Enrico
    Martelletti, Paolo
    TOXINS, 2023, 15 (01)
  • [33] OnabotulinumtoxinA Treatment Satisfaction among Patients with Chronic Migraine
    Tockhorn-Heidenreich, A.
    Ford, J.
    Jackson, J.
    Ye, W. Wenyu
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 891 - 891
  • [34] Healthcare Resource Utilization in Adult Patients Treated with OnabotulinumtoxinA for Chronic Migraine: Results from the COMPEL Study
    Rothrock, J. F.
    Stark, R.
    Sommer, K.
    Blumenfeld, A. M.
    HEADACHE, 2019, 59 : 108 - 109
  • [35] Healthcare Resource Utilization in Adult Patients Treated With OnabotulinumtoxinA for Chronic Migraine: Results From the COMPEL Study
    Rothrock, John F.
    Stark, Richard
    Sommer, Katherine
    Blumenfeld, Andrew M.
    CEPHALALGIA, 2019, 39 : 235 - 235
  • [36] Healthcare resource utilization in adult patients treated with onabotulinumtoxinA for chronic migraine: results from the COMPEL study
    Rothrock, John F.
    Stark, Richard
    Sommer, Katherine
    Blumenfeld, Andrew M.
    JOURNAL OF HEADACHE AND PAIN, 2019, 20
  • [37] Healthcare Resource Utilization in Adult Patients Treated With OnabotulinumtoxinA for Chronic Migraine: Results From the COMPEL Study
    Rothrock, John F.
    Stark, Richard
    Sommer, Katherine
    Blumenfeld, Andrew M.
    NEUROLOGY, 2020, 94 (15)
  • [38] OnabotulinumtoxinA in Chronic Migraine; Predicting response to treatment based on headache days at baseline
    Buture, Alina
    Ghabeli, Ali J.
    Khalil, Modar
    Ahmed, Fayyaz
    CEPHALALGIA, 2017, 37 : 114 - 114
  • [39] ONABOTULINUMTOXINA IN CHRONIC MIGRAINE; PREDICTING RESPONSE TO TREATMENT BASED ON HEADACHE DAYS AT BASELINE
    Khalil, M.
    Buture, A.
    Nimeri, R.
    Ahmed, F.
    CEPHALALGIA, 2016, 36 : 118 - 119
  • [40] ONABOTULINUMTOXINA IN CHRONIC MIGRAINE; PREDICTING RESPONSE TO TREATMENT BASED ON HEADACHE DAYS AT BASELINE
    Kalaitzaki, S.
    Papantonakis, E.
    Panagopoulos, G.
    Tsiara, S.
    CEPHALALGIA, 2016, 36 : 118 - 118
12345